Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/26 16:10 | 3/2/26 | MRNA | Health | BioPrd | Biological Products, (No Diag | Klinger Shannon Thyme | MA | O | GC | 4 | S.d | -815 | 51.13 | 0 | -16 | 60 | D | |||||||||||||||
2/25/26 16:49 | 2/23/26 | MRNA | Health | BioPrd | Biological Products, (No Diag | Hoge Stephen | MA | O | P | 3 | S.d | -7,841 | 48.82 | 0 | -161 | 1,613 | D | |||||||||||||||
12/15/25 09:00 | 12/11/25 | MRNA | Health | BioPrd | Biological Products, (No Diag | Afeyan Noubar | MA | D | 1 | S.d | -703 | 29.49 | 0 | -24 | 0 | 6,856 | I | |||||||||||||||
12/11/25 16:16 | 12/9/25 | MRNA | Health | BioPrd | Biological Products, (No Diag | Hussain Abbas | MA | D | 2 | S | -23 | 27.75 | 0 | -1 | 2 | D | ||||||||||||||||
12/2/24 16:26 | 11/29/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Mock James M | MA | O | CFO | 1 | S.d | -61 | 42.79 | 0 | -1 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |